The interesting yet challenging observations we have experienced while addressing the pathophysiology and therapeutic manipulation of the CD137-CD137L co-stimulation system in SLE, have let us appreciate more thoroughly the complexity of the co-stimulation system in mediating the pathophysiology of SLE. The gene discussed is TNFSF9; the disease is systemic lupus erythematosus.